Clinical Trial Update: Gemzar, Cisp, Sunitinib Urothelial Ca [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for a combination of gemcitabine, cisplatin, and sunitinib in urothelial cancer; the study has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• Sutent (sunitinib)

Snippet

Sponsor: US Oncology Research | Conditions: Urothelial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-02